Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

IZEA vs ABVE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IZEA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–1 Matrix Metrics)

IZEA Overall Winner 6-Pillar Tally: IZEA 5 – 1 ABVE Matrix Metrics: IZEA 8 – 1 ABVE

As of Nov 20, 2026, IZEA Worldwide, Inc. (IZEA) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IZEA carries a Unified Composite Score of 44.5/100 (HOLD) at $2.31 (21.0x Forward P/E, -19.0% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin).

  • Technical & Structure Timing Caution: IZEA is currently in a Breakdown options structure phase (RSI 49.0); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IZEA vs ABVE
IZEA NASDAQ Head-to-Head Winner
IZEA Worldwide, Inc. Common Stock
Services-Advertising
$2.31
+0.43% 1D
Market Cap $39.8M
TTM Revenue $25M
Forward P/E 21.0x
Beta / 30D Vol 0.68β · 67% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 50.0 Fund 43.0 Flow 56.0 Mom 58.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.0 · SMA20: $2.29 · SMA50: $2.40
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67

6-Pillar Scorecard Institutional Category Breakdown (IZEA 5 – 1 ABVE)

Columns: Metric · IZEA · ABVE
1. Valuation Multiples IZEA
Forward P/E 21.0x N/M
Trailing P/E 40.0x N/M
PEG Ratio 2.67x N/M
EV / Revenue N/M 0.1x
2. Growth & Scale IZEA
Revenue Growth (YoY) -23.3% -45.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $25M $295M
Market Cap $39.8M $30.0M
3. Profitability & Quality IZEA
Gross Margin 41.5% -2.8%
Operating Margin -19.0% -23.2%
Net Profit Margin -12.5% -23.4%
Return on Equity (ROE) -6.4% 0.0%
4. Balance Sheet & Cash Flow IZEA
Cash Generation (TTM) -$2.7M -$40M EBITDA
Cash Flow Margin -11.1% -13.7% EBITDA Mgn
Net Cash / Leverage $46M Net Cash 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVE
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 81.2% (89th %ile) 148.3% (8th %ile)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat IZEA
OpEx & R&D Intensity 60.5% of Rev ($15M) 20.4% of Rev ($60M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Advertising Agencies Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IZEA (8) vs ABVE (1)
Institutional Metric IZEA ABVE Criterion Row Edge
Market Capitalization
Scale
$39.8M $30.0M Larger Scale Tie
Trailing P/E Ratio
Valuation
40.0x N/M Lower Multiple IZEA
Forward P/E Ratio
Valuation
21.0x N/M Lower Multiple IZEA
Revenue Growth (YoY)
Growth
-23.3% -45.0% Higher Growth IZEA
Operating Margin (TTM)
Profitability
-19.0% -23.2% Higher Margin IZEA
Net Profit Margin
Profitability
-12.5% -23.4% Higher Margin IZEA
Return on Equity (ROE)
Capital Efficiency
-6.4% 0.0% Higher ROE ABVE
52-Week Range Position
Momentum
5% ($2–$5) 0% ($0–$7) Stronger Trend IZEA
Beta / 30D Volatility
Risk Regime
0.68β · 67% Vol 4.10β · 310% Vol Lower Realized Risk IZEA
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite IZEA
Trailing 12M Revenue (USD)
Operating Scale
$25M $295M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.5% -2.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.67x PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$2.7M ($46M Net Cash) -$40M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IZEA +71.38 pp
IZEA: -7.8% · ABVE: -79.18%
3M Horizon IZEA +92.77 pp
IZEA: +1.34% · ABVE: -91.43%
6M Horizon IZEA +71.88 pp
IZEA: -23.79% · ABVE: -95.67%
1Y Horizon IZEA +69.42 pp
IZEA: -24.85% · ABVE: -94.27%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IZEA vs ABVE. Trailing 12-month operating profitability (IZEA -19.0% vs ABVE -23.2%) and valuation multiples (IZEA 21.0x vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IZEA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$25M
Gross Margin41.5%
Op. Margin-19.0%
ROE / Fwd P/E-6.4% · 21.0x
ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IZEA BREAKDOWN
148d in phase · OBV NEUTRAL
Current IV 81.2%
IV Percentile 89th %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact IZEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IZEA Moat Profile Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $39.8M market capitalization and -19.0% operating margin.
OpEx & R&D Reinvestment 60.5% of Rev ($15M)
90D Engineering Disclosures 0 Published
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published

Investor FAQ IZEA vs ABVE Key Questions & Quantitative Answers

As of Nov 20, 2026, IZEA Worldwide, Inc. (IZEA) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IZEA carries a Unified Composite Score of 44.5/100 (HOLD) at $2.31 (21.0x Forward P/E, -19.0% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin). Technical & Structure Timing Caution: IZEA is currently in a Breakdown options structure phase (RSI 49.0); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IZEA leads the Growth & Scale pillar: IZEA posts -23.3% YoY revenue growth and +0.0% YoY earnings growth on $25M TTM revenue (41.5% gross margin, -19.0% operating margin), compared with ABVE at -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin). On trailing 12-month operating scale, IZEA generates $25M in USD-normalized revenue versus $295M for ABVE. In operating R&D and SG&A reinvestment, IZEA deploys 60.5% of Rev ($15M) (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($60M) (0 disclosures) for ABVE.

IZEA screens cheaper on headline valuation multiples. IZEA trades at 21.0x Forward P/E, 40.0x Trailing P/E, 2.67x PEG, and N/M EV/Revenue (-11.1% FCF margin), whereas ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IZEA (-6.4% ROE) versus ABVE (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, IZEA carries 81.2% implied volatility (89th %ile, Extreme (>80th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.68β · 67% Vol realized risk). By comparison, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.